Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  Diagnostic agents >  Medical Imaging Drugs >  iodoxamic acid

iodoxamic acid

Basic information Safety Supplier Related

iodoxamic acid Basic information

Product Name:
iodoxamic acid
Synonyms:
  • 3-[3-[2-[2-[2-[3-(3-carboxy-2,4,6-triiodoanilino)-3-oxopropoxy]ethoxy]ethoxy]ethoxy]propanoylamino]-2,4,6-triiodobenzoic acid
  • 3,3'-[(1,16-Dioxo-4,7,10,13-tetraoxahexadecane-1,16-diyl)diimino]bis(2,4,6-triiodobenzoic acid)
  • 3,3'-[Ethylenebis(oxyethyleneoxyethylenecarbonylimino)]bis(2,4,6-triiodobenzoic acid)
  • B-10610
  • BC-17
  • SQ-21982
  • Iodoxamic
  • iodoxamic acid
CAS:
31127-82-9
MF:
C26H26I6N2O10
MW:
1287.92
EINECS:
250-478-1
Mol File:
31127-82-9.mol
More
Less

iodoxamic acid Chemical Properties

Boiling point:
977.7±65.0 °C(Predicted)
Density 
2.423±0.06 g/cm3(Predicted)
pka
pKa 1.8/2.8(H2O,t = 25) (Uncertain)
More
Less

iodoxamic acid Usage And Synthesis

Originator

Endobil,Bracco

Uses

Diagnostic aid (radiopaque medium).

Definition

ChEBI: Iodoxamic acid is an organic molecular entity.

Manufacturing Process

148.5 g 4,7,10,13-tetraoxahexadecane-1,16-dinitrile (U.S. Patent No. 2,401,607) was added to a solution of 232 g (2.45 mol) concentrate sulfuric acid in 290 ml absolute ethanol at 15°C. The mixture was heated at reflux for 15 hours, cooled and poured into 1000 g ice and 250 g ammonium sulfate. It was extracted with methylene chloride, dried and a solvent was removed in vacuum. The residue was distilled to give 4,7,10,13-tetraoxahexadecane-1,16- dicarbonic acid dimethyl ester; BP: 190°-195°C/0.005 mm Hg.
1 mol above prepared diester was saponificated with equivalent of NaOH in water. The reaction mixture was heated for 90 minutes. On cooling it was extracted with ether and the water layer was evaporated to dryness. The residue was washed with acetone. The obtained disodium salt of 4,7,10,13- tetraoxahexadecane-1,16-dicarbonic acid (yield 100%; MP: 102°-104°C) was acidified with calculated quantity of HCl to give the dicarbonic acid. The solvent was evaporated to dryness. Acetone was added to the residue for removing a by-product (sodium chloride) by filtration. Acetone was evaporated and the residue was extracted with ether, dried and evaporated. The residual liquid was 4,7,10,13-tetraoxahexadecane-1,16-dicarbonic acid.
100 ml thionyl chloride was cautious added to 56 g above prepared diacid and heated at 40°-50°C and excess thionyl chloride was distilled in vacuum. The residue was the 4,7,10,13-tetraoxahexadecane-1,16-dicarbonic acid dichloride. The desired iodoxamic acid was prepared from above dichloride and 3-amino-2,4,6-trijode benzoic acid, in dimethylacetamide

brand name

Endobil (Bracco Industria Chimica S.p.A.,Italy); Endomirabil (Bracco Industria Chimica S.p.A., Italy); Videocolangio (Bracco Industria Chimica S.p.A., Italy).

Therapeutic Function

Diagnostic aid

iodoxamic acidSupplier

Dideu Industries Group Limited
Tel
+86-29-89586680 +86-15129568250
Email
1026@dideu.com
Shaanxi Dideu Medichem Co. Ltd
Tel
+86-029-89586680 +86-18192503167
Email
1026@dideu.com
Hubei xin bonus chemical co. LTD
Tel
86-13657291602
Email
linda@hubeijusheng.com
Baoji Didu Pharmaceutical and Chemical Co., Ltd
Tel
029-61856358 15829046862
Email
1035@dideu.com